ASHLEY KRUPA: Open Payments
NPI 1629811336 · EAST LONGMEADOW, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,944 in 84 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $517 · 2025 $1,944
Food & beverage: $1,944
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $816 |
| Lilly USA, LLC | 8 | $280 |
| Novo Nordisk Inc | 8 | $180 |
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Axsome Therapeutics, Inc. | 3 | $97 |
| PFIZER INC. | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $49 |
| Madrigal Pharmaceuticals | 1 | $39 |
| Amgen Inc. | 1 | $32 |
Products named: VRAYLAR, UBRELVY, KISUNLA, MOUNJARO, Auvelity, Wegovy, QULIPTA, Ozempic.
Industry payments across MA — which companies pay providers there.
